Umarova Khadizhat Eduardovna (candidate of medical sciences, The main bureau of medical and social expertise in the Kabardino-Balkarian Republic)
Tlupova Tamara Gumarovna (candidate of medical sciences, associate professor, Kabardino-Balkarian State University im.H.M.Berbekova)
Medov Artem Zaurbekovich (Kabardino-Balkarian State University im.H.M.Berbekova)
Irugova Elmira Zalimkhanovna (Kabardino-Balkarian State University im.H.M.Berbekova)
Teuvazhukova Diana A. (Kabardino-Balkarian State University im.H.M.Berbekova)
| |
An important breakthrough in the treatment of a number of eye diseases was the use of drugs that block angiogenesis. Currently, several drugs have been developed and used that can block vascular endothelial growth factor (vascular endothelial growth factor — VEGF) at different stages. The anti-VEGF drug "Eylea" used by us allowed to preserve and improve visual functions in patients with exudative and hemorrhagic forms of age-related macular degeneration, to reduce the duration of hospital stay, to improve subjective feelings during treatment. All this reduces the risks of disability of the population, especially in the older age group.
Keywords:neoangiogenesis inhibitors, Central Chorio-retinal dystrophy, primary disability
|
|
| |
|
Read the full article …
|
Citation link:
Umarova K. E., Tlupova T. G., Medov A. Z., Irugova E. Z., Teuvazhukova D. A. Timely antiangiogenic therapy — factor to reduce disability during exudative and hemorrhagic forms of age-related macular degeneration // Современная наука: актуальные проблемы теории и практики. Серия: Естественные и Технические Науки. -2018. -№12/2. -С. 79-82 |
|
|
